A 12-Month, Open-Label Safety Study of PTl-125 in Mild-to-moderate Alzheimer’s Disease Patients
Criteria:-Be between the ages of 50-85
-Must have a clinical diagnosis of dementia, due to possible or probable AD
-Must be living at home, senior residential setting, or an institutional setting without the need for continuous
-Must be able to read, write and speak English or Spanish
-Non Smoker for at least 3 years